CLOUGH CAPITAL PARTNERS L P - CARDIOME PHARMA CORP ownership

CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 32 filers reported holding CARDIOME PHARMA CORP in Q1 2015. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
CLOUGH CAPITAL PARTNERS L P ownership history of CARDIOME PHARMA CORP
ValueSharesWeighting
Q1 2018$4,816,000
+16.5%
2,075,663
-22.2%
0.46%
+33.6%
Q4 2017$4,135,000
-32.6%
2,667,585
-7.3%
0.34%
-16.1%
Q3 2017$6,132,000
-52.9%
2,878,9850.0%0.41%
-54.5%
Q2 2017$13,013,000
+46.1%
2,878,985
-2.7%
0.90%
+59.8%
Q1 2017$8,905,000
+5.4%
2,958,415
-3.4%
0.56%
+0.9%
Q4 2016$8,449,000
-11.8%
3,061,0640.0%0.56%
+12.0%
Q3 2016$9,581,000
-9.2%
3,061,064
+48.5%
0.50%
-11.5%
Q2 2016$10,553,000
+26.2%
2,061,064
+0.8%
0.56%
+43.4%
Q1 2016$8,363,000
-40.7%
2,044,653
+17.6%
0.39%
-40.2%
Q4 2015$14,098,000
+5.4%
1,738,353
+9.7%
0.66%
+14.0%
Q3 2015$13,370,000
+80.4%
1,584,083
+101.1%
0.58%
+104.2%
Q2 2015$7,411,000
+34.0%
787,583
+31.9%
0.28%
+54.6%
Q1 2015$5,530,000
+16.6%
597,183
+16.5%
0.18%
+7.6%
Q4 2014$4,741,000
+6.4%
512,533
+2.7%
0.17%
+1.8%
Q3 2014$4,456,000
+57.3%
499,004
+38.3%
0.17%
+87.6%
Q2 2014$2,832,000360,7210.09%
Other shareholders
CARDIOME PHARMA CORP shareholders Q1 2015
NameSharesValueWeighting ↓
Alistair Capital Management, L.L.C. 917,400$5,715,0002.56%
Fortress Investment Group LLC 2,481,596$15,460,0000.24%
PERKINS CAPITAL MANAGEMENT INC 14,000$87,0000.06%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,332,260$8,386,0000.02%
TFS CAPITAL LLC 26,116$163,0000.01%
GROUP ONE TRADING, L.P. 54,815$342,0000.01%
Renaissance Technologies 218,913$1,364,0000.00%
Alberta Investment Management Corp 19,140$128,0000.00%
OAK RIDGE INVESTMENTS LLC 11,055$69,0000.00%
SUMMIT SECURITIES GROUP LLC 600$4,0000.00%
View complete list of CARDIOME PHARMA CORP shareholders